-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Pharvaris, Raises Price Target to $39

Benzinga·12/04/2025 13:54:43
Listen to the news
Guggenheim analyst Debjit Chattopadhyay maintains Pharvaris (NASDAQ:PHVS) with a Buy and raises the price target from $32 to $39.